PARLIAMENT QUESTION: DEVELOPMENT OF INDIGENOUS ANTIBIOTICS

• Nafithromycin is India's first indigenously discovered antibiotic, developed by Wockhardt Ltd with partial public funding via BIRAC (DBT), targeting Community Acquired Bacterial Pneumonia (CABP).
• A novel macrolide (lactone ketolide, code WCK 4873), brand name "Miqnaf", marketed as a 400 mg tablet, 3-day once-daily regimen.
• Flagship case study for Antimicrobial Resistance (AMR) containment + Atmanirbhar Bharat in drug discovery — directly examinable under GS-III Sci-Tech and Health.